NEUROCOGNITIVE DISORDERS
Clinical trials for NEUROCOGNITIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROCOGNITIVE DISORDERS trials appear
Sign up with your email to follow new studies for NEUROCOGNITIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy aims to make Alzheimer's drug safer
Disease control OngoingThis study tests whether changing the dose schedule of donanemab can lower the risk of a brain swelling side effect called ARIA-E while still clearing amyloid plaques. About 1,175 adults with early symptomatic Alzheimer's will receive different dosing regimens over 91 weeks. The …
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 09:02 UTC
-
Zapping the brain to beat apathy: new hope for seniors?
Symptom relief OngoingThis study explores whether a gentle, non-invasive brain stimulation technique called tDCS, combined with computer-based cognitive training, can help reduce apathy in older adults with mild cognitive impairment. Apathy is a common problem that makes people lose interest and motiv…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC